Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Aug;183(2):382-384.
doi: 10.1111/bjd.18958. Epub 2020 Apr 13.

Implementation of dupilumab in routine care of atopic eczema: results from the German national registry TREATgermany

S Abraham  1 , E Haufe  2 , I Harder  3 , A Heratizadeh  4 , A Kleinheinz, A Wollenberg, E Weisshaar, M Augustin, F Wiemers, A Zink, T Biedermann, R von Kiedrowski, M Hilgers, M Worm, M Pawlak, M Sticherling, I Fell, C Handrick, K Schäkel, P Staubach, A Asmussen, B Schwarz, M Bell, K Neubert, I Effendy, T Bieber, B Homey, B Gerlach, E Tchitcherina, M Stahl, U Schwichtenberg, J Rossbacher, P Buck, M Mempel, S Beissert  1 , T Werfel  4 , S Weidinger  3 , J Schmitt  2 ; TREATgermany study group
Affiliations

Implementation of dupilumab in routine care of atopic eczema: results from the German national registry TREATgermany

S Abraham et al. Br J Dermatol. 2020 Aug.
No abstract available

PubMed Disclaimer

Comment in

  • Kurz notiert.
    Facharztmagazine R. Facharztmagazine R. MMW Fortschr Med. 2021 Feb;163(2):57. doi: 10.1007/s15006-021-9582-7. MMW Fortschr Med. 2021. PMID: 33527298 German. No abstract available.

References

    1. Schmitt J, Abraham S, Trautmann F et al. Usage and effectiveness of systemic treatments in adults with severe atopic eczema: first results of the German Atopic Eczema Registry TREATgermany. J Dtsch Dermatol Ges 2017; 15:49-60.
    1. Heratizadeh A, Haufe E, Stölzl D et al. Baseline characteristics, disease severity and treatment history of patients with atopic dermatitis included in the German AD registry TREATgermany. J Eur Acad Dermatol Venereol 2020; DOI: 10.1111/jdv.16078
    1. Blauvelt A, de Bruin-Weller M, Gooderham M et al. Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomized, double-blinded, placebo-controlled, phase 3 trial. Lancet 2017; 389:2287-303.
    1. Simpson EL, Bieber T, Guttman-Yassky E et al. Two phase 3 trials of dupilumab versus placebo in atopic dermatitis. N Engl J Med 2016; 375:2335-48.
    1. De Bruin-Weller M, Thaçi D, Smith CH et al. Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: a placebo-controlled, randomized phase III clinical trial (LIBERTY AD CAFÉ). Br J Dermatol 2018; 178:1083-101.

Publication types

Substances